Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Chrysant

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Archives of Internal Medicine|December 1, 1977
Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differencesS G Chrysant, F G Dunn, J G De Carvalho, et al.
American Heart Journal|January 8, 1999
Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators GroupJ M Neutel, V Buckalew, S G Chrysant, et al.
Journal of Clinical Pharmacology|January 1, 1992
Antihypertensive and metabolic effects of single and combined atenolol regimensS G Chrysant, C Chappel, D J Farnham, et al.
Clinical Cardiology|November 1, 1985
Hemodynamic and metabolic effects of enalapril in patients with heart failureS G Chrysant, S Gollub, M I Dunn, et al.
Circulation|February 1, 1978
Hemodynamic correlates of saralasin-induced arterial pressure changesJ G de Carvalho, F G Dunn, D C Kem, et al.
The American Journal of Cardiology|July 15, 1989
Effectiveness of doxazosin in systemic hypertensionR P Ames, S G Chrysant, F Gonzalez, et al.
Journal of Clinical Pharmacology|February 1, 1995
Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable anginaN R Cutler, J Eff, G Fromell, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1979
Racial differences in pressure, volume and renin interrelationships in essential hypertensionS G Chrysant, K Danisa, D C Kem, et al.
The Journal of Urology|July 1, 1995
Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter studyJ Y Gillenwater, R L Conn, S G Chrysant, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1981
Magnesium and potassium interrelationships, experimental and clinicalR Whang, T O Oei, J K Aikawa, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Archives of Internal Medicine|December 1, 1977
Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differencesS G Chrysant, F G Dunn, J G De Carvalho, et al.
American Heart Journal|January 8, 1999
Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators GroupJ M Neutel, V Buckalew, S G Chrysant, et al.
Journal of Clinical Pharmacology|January 1, 1992
Antihypertensive and metabolic effects of single and combined atenolol regimensS G Chrysant, C Chappel, D J Farnham, et al.
Clinical Cardiology|November 1, 1985
Hemodynamic and metabolic effects of enalapril in patients with heart failureS G Chrysant, S Gollub, M I Dunn, et al.
Circulation|February 1, 1978
Hemodynamic correlates of saralasin-induced arterial pressure changesJ G de Carvalho, F G Dunn, D C Kem, et al.
The American Journal of Cardiology|July 15, 1989
Effectiveness of doxazosin in systemic hypertensionR P Ames, S G Chrysant, F Gonzalez, et al.
Journal of Clinical Pharmacology|February 1, 1995
Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable anginaN R Cutler, J Eff, G Fromell, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1979
Racial differences in pressure, volume and renin interrelationships in essential hypertensionS G Chrysant, K Danisa, D C Kem, et al.
The Journal of Urology|July 1, 1995
Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter studyJ Y Gillenwater, R L Conn, S G Chrysant, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1981
Magnesium and potassium interrelationships, experimental and clinicalR Whang, T O Oei, J K Aikawa, et al.
Pageof 11